Aurigene Signs Long-Term Manufacturing Pact With Global Pharma Firm

Aurigene has made a long-term deal with a global medicine company.

The other company’s name was not shared.

Aurigene will help make and supply several medicines.

These medicines may be sold in the United States, Europe, Canada and emerging markets.

The work includes moving technical knowledge and developing manufacturing processes.

It also includes testing, increasing production and checking that the processes work properly.

Aurigene will then make the products commercially and supply them over the long term.

Aurigene is a wholly owned arm of Dr Reddy's Laboratories.